First COVID-19 vaccine to receive final FDA approval

The Food and Drug Administration (FDA) of the United States on Monday finally approved the coronavirus vaccine developed by the American company Pfizer and its German partner BioNTech. This was reported in a press release from the regulator.

Pfizer is the first COVID-19 vaccine to receive final FDA approval. Prior to that – in December 2020 – Pfizer’s vaccine was fast-tracked for emergency use by the FDA. Vaccines from Moderna and Johnson & Johnson later received similar approval.

“The FDA today approved the first COVID-19 vaccine. The drug was known as [the] COVID-19 vaccine by Pfizer / BioNTech and will now be marketed under the name Comirnaty [as a drug] to prevent COVID-19 for people aged from 16 years old, “the message says.

As noted in the press release, as part of the previously issued authorization for the use of this vaccine in emergency situations, it will continue to be available for people aged 12 to 15 years, and the authorization for the use of a booster dose of the drug for people with weakened immunity will continue to be valid.

Leave a Comment